Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Research article

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

Yun Choi, Ho Won Lee, Jaetae Lee and Yong Hyun Jeon*

BMC Cancer 2013, 13:143  doi:10.1186/1471-2407-13-143

Article Metrics

1361
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 36 accesses
  • Last 365 days: 519 accesses
  • All time: 1361 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information